1st Quarter - Report

MICHAEL N. MCCARTY LAW OFFICE PLLC for AMERICAN MEDICAL TECHNOLOGISTS

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

CARES Act provisions amending Sec. 216 of the Protecting Access to Medicare Act of 2014 (PAMA) and other legislation affecting payments under the Medicare Clinical Laboratory Fee Schedule.

LobbyistCovered position, as disclosed
MICHAEL N MCCARTY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Appropriations to CDC for harmonization of diagnostic laboratory test results; Appropriations for CDC initiative to establish pediatric reference intervals for clinical diagnostic testing; proposed legislation to establish clinical laboratory workforce development initiatives under the Public Health Service Act and other potential legislative vehicles; prospective legislation to regulate in vitro clinical diagnostic tests, including the Verifying Accurate, Leading-edge IVCT Development (VALID) Act (H.R.6102; S.3404); and the Verified Innovative Testing in American Laboratories (VITAL) Act (S.3512).

LobbyistCovered position, as disclosed
MICHAEL N MCCARTY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3404 (116th), H.R. 6102 (116th), S. 3512 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.